BRAZE INC-A
BRZENASDAQ🏆 #1808 by market capEarnings Dec 7US Equity
$25.38▲ $2.44 (+9.61%)
LiveTrack BRZE
Get earnings, price moves & breaking news on Telegram
24h▲ 9.6%
7d▼ 2.0%
14d▲ 2.0%
30d▼ 25.5%
ytd▼ 26.0%
1y▼ 10.7%
🏦Market Cap
$2.86B
Small Cap
📈Revenue Growth (YoY)
+24.4%
Healthy
📊Gross Margin
66.3%
High
💵FCF Margin
10.0%
Healthy
⚖️P/S Ratio
3.1x
Fair
Otter Score
80
Good
BRAZE INC-A
BRZEAnalyst Ratings
Price
$25.38
Total
25
Raised
1
Lowered
0
Avg PT
$37.27
H / L
$52 / $32
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
Piper Sandler | Reiterated | Overweight | 2026-09-09 | $30.00 | +18.20% |
Raymond James | Reiterated | Outperform | 2026-09-09 | $33.00 | +30.00% |
JP Morgan | Reiterated | Overweight | 2026-09-09 | — | — |
Citizens | Reiterated | Market Outperform | 2026-09-09 | — | — |
Stephens & Co. | Reiterated | Overweight | 2026-09-09 | — | — |
BTIG | Reiterated | Buy | 2026-09-09 | $35.00 | +37.90% |
UBS | Reiterated | Buy | 2026-09-09 | $32.00 | +26.10% |
DA Davidson | Reiterated | Buy | 2026-09-09 | $40.00 | +57.60% |
Needham | Reiterated | Buy | 2026-09-09 | $50.00 | +97.00% |
Canaccord Genuity | Reiterated | Buy | 2026-09-09 | $37.00 | +45.80% |
Barclays | Reiterated | Overweight | 2026-09-02 | $38.00 | +49.80% |
Oppenheimer | Reiterated | Outperform | 2026-08-27 | $36.00 | +41.90% |
TD Cowen | Reiterated | Buy | 2026-08-27 | — | — |
Citigroup | Reiterated | Buy | 2026-05-29 | $59.00 | +132.50% |
Mizuho | Reiterated | Outperform | 2026-05-28 | — | — |
Cantor Fitzgerald | Reiterated | Overweight | 2026-05-28 | $38.00 | +49.80% |
Goldman Sachs | Reiterated | Buy | 2026-03-25 | $38.00 | +49.80% |
Stifel | Reiterated | Buy | 2026-03-25 | — | — |
Wells Fargo | Reiterated | Overweight | 2025-12-10 | $45.00 | +77.30% |
JMP Securities | Reiterated | Market Outperform | 2025-09-05 | $52.00 | +104.90% |
Macquarie | Reiterated | Neutral | 2025-06-06 | $39.00 | +53.70% |
Loop Capital | Reiterated | Buy | 2025-06-06 | — | — |
Citizens Capital Markets | Reiterated | Market Outperform | 2025-03-28 | — | — |
Scotiabank | Upgraded | Sector Perform → Sector Outperform | 2024-07-10 | $56.00 | +120.70% |
Cowen & Co. | Reiterated | Outperform | 2022-09-13 | — | — |
Institution
Piper Sandler
Reiterated · Overweight · 2026-09-09
$30.00
+18.20%
Raymond James
Reiterated · Outperform · 2026-09-09
$33.00
+30.00%
JP Morgan
Reiterated · Overweight · 2026-09-09
—
—
Citizens
Reiterated · Market Outperform · 2026-09-09
—
—
Stephens & Co.
Reiterated · Overweight · 2026-09-09
—
—
BTIG
Reiterated · Buy · 2026-09-09
$35.00
+37.90%
UBS
Reiterated · Buy · 2026-09-09
$32.00
+26.10%
DA Davidson
Reiterated · Buy · 2026-09-09
$40.00
+57.60%
Needham
Reiterated · Buy · 2026-09-09
$50.00
+97.00%
Canaccord Genuity
Reiterated · Buy · 2026-09-09
$37.00
+45.80%
Barclays
Reiterated · Overweight · 2026-09-02
$38.00
+49.80%
Oppenheimer
Reiterated · Outperform · 2026-08-27
$36.00
+41.90%
TD Cowen
Reiterated · Buy · 2026-08-27
—
—
Citigroup
Reiterated · Buy · 2026-05-29
$59.00
+132.50%
Mizuho
Reiterated · Outperform · 2026-05-28
—
—
Cantor Fitzgerald
Reiterated · Overweight · 2026-05-28
$38.00
+49.80%
Goldman Sachs
Reiterated · Buy · 2026-03-25
$38.00
+49.80%
Stifel
Reiterated · Buy · 2026-03-25
—
—
Wells Fargo
Reiterated · Overweight · 2025-12-10
$45.00
+77.30%
JMP Securities
Reiterated · Market Outperform · 2025-09-05
$52.00
+104.90%
Macquarie
Reiterated · Neutral · 2025-06-06
$39.00
+53.70%
Loop Capital
Reiterated · Buy · 2025-06-06
—
—
Citizens Capital Markets
Reiterated · Market Outperform · 2025-03-28
—
—
Scotiabank
Upgraded · Sector Perform → Sector Outperform · 2024-07-10
$56.00
+120.70%
Cowen & Co.
Reiterated · Outperform · 2022-09-13
—
—
One row per institution · price target from the firm's latest published target